At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 enrolled
Drug / intervention
Harmoni Modular Intraocular Lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Visual and Refractive Outcomes of The ClarVista HARMONI™ Modular Intraocular Lens System
In Brief
A clinical study evaluating Harmoni Modular Intraocular Lens and Optic Exchange for Cataract and Aphakia. Completed, enrolled 150 participants.
Detailed Summary
The purpose of this study was to evaluate visual and refractive outcomes with the use of the HARMONI™ Modular Intraocular Lens (HMIOL) System implantation, assembly, and optic exchange in subjects undergoing cataract surgery.
Study Details
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
Primary CompletionDec 2017
First PostedSep 2018
TodayJul 2026
First PostedSep 24, 2018
Enrollment StartJan 9, 2016
Primary CompletionDec 14, 2017
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.8 years ago
Interventions
Harmoni Modular Intraocular Lensdevice
Two-component system consisting of a base and a separate optic that allows for an intraoperative exchange of the optic only without direct manipulation of the capsular bag.
Optic Exchangeprocedure
Removal of one optic and replacement with another for the purpose of improving refractive outcomes